Doxycycline Hydrochloride + Lactic Acid BacillusThird Party Manufacturing in India

Doxycycline Hydrochloride + Lactic Acid Bacillus works by combining broad-spectrum antimicrobial activity with protective intestinal microflora support. Doxycycline inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, while Lactic Acid Bacillus spores germinate in the intestine to restore the natural microfloral balance. It eliminates pathogenic organisms while safeguarding the GI tract to help the body recover from infection without developing antibiotic-associated diarrhea. Unlike standard tetracycline products, it protects intestinal health during extended therapy. It is highly effective and well-tolerated.

Therapeutic Uses

• Acne Vulgaris: It treats severe inflammatory dermatological acne by reducing Propionibacterium acnes levels.
• Respiratory Tract Infections: It manages atypical pneumonia and chronic bronchitis flare-ups caused by susceptible strains.
• Infectious Diarrhea Prophylaxis: It treats bacterial microbial infections while actively preventing secondary gastrointestinal imbalances.

Why Manufacturers Choose Doxycycline Hydrochloride + Lactic Acid Bacillus

Including a probiotic alongside doxycycline addresses a common prescribing concern: antibiotic-induced stomach upset. Securing Doxycycline Hydrochloride + Lactic Acid Bacillus third party manufacturing in India allows brands to provide a well-tolerated antibiotic option. Our production facilities are WHO-GMP certified, utilizing advanced dry-compounding methods to protect the viability of the beneficial spores during processing under CAS number 10592-13-9.